SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-024285
Filing Date
2023-05-25
Accepted
2023-05-25 17:00:32
Documents
12
Period of Report
2023-05-25
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K ktra-20230525.htm   iXBRL 8-K 76726
  Complete submission text file 0000950170-23-024285.txt   201583

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ktra-20230525_pre.xml EX-101.PRE 11469
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ktra-20230525_lab.xml EX-101.LAB 18331
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ktra-20230525.xsd EX-101.SCH 2389
6 EXTRACTED XBRL INSTANCE DOCUMENT ktra-20230525_htm.xml XML 4692
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 23961810
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences